NCT02279199

Brief Summary

The purpose of this study is to find out if gross motor skills of children and young adults with bleeding disorders are different from those without bleeding disorders. The investigators will use the standardized motor test the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2 tm). The second purpose is to establish if history of joint disease secondary to bleeding affects gross motor skills.

  1. 1.Participants and setting: Subjects will include up to 100 male youth and young adults, ages 4 to 21, recruited from the patient population of the Hemophilia Treatment Center at OHSU. A mailing that describes the study may be sent to all potential subjects who receive care through the Hemophilia Treatment Center at OHSU. Data collection will occur at either clinic visits or in the home. Information, including history of change in joint structure and synovium, from existing bleeding disorder repositories at OHSU will also be used.
  2. 2.Design and Procedures: Research will be done using a prospective, cross-sectional study design to examine any relationship between a diagnosis of bleeding disorder and gross motor development. The gross motor ability of children and young adults with bleeding disorders who meet the inclusion criteria will be compared to sex-specific normative data from a standardized motor test. Information about age, type of hemophilia, presence of an inhibitor, type of management used, body composition, range of motion, and hand strength will also be collected through direct measurement and chart review. The information collected will be entered into a repository. A subject may choose to opt out of the repository while still participating in the research study. In addition, information from a current hemophilia repository will be compared to gross motor ability scores to determine if joint disease is related to skill level in this group of people.
  3. 3.Proposed analyses: Two-tailed t tests and logistic regression will be used to determine if there are any significant differences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 10, 2014

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 31, 2014

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

8 years

First QC Date

February 10, 2014

Last Update Submit

May 9, 2023

Conditions

Keywords

hemophiliajoint healthmotor developmentmotor proficiency

Outcome Measures

Primary Outcomes (1)

  • Motor Proficiency

    Motor proficiency of children and young adults with hemophilia compared to age-matched standardized norms

    At point of testing

Secondary Outcomes (1)

  • Joint health using Hemophilia Joint Health Score (HJHS)

    at point of testing

Study Arms (2)

Control

Normative data from standardized assessment

Hemophilia

Persons aged 4-21 with any severity of hemophilia A or B

Eligibility Criteria

Age4 Years - 21 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and young adults with hemophilia A or hemophilia B, between the ages of 4 years, 0 months to 21 years, 11 months.

You may qualify if:

  • Patient of the Hemophilia Treatment Center at OHSU
  • Male
  • Aged 4 years, 0 months to 21 years, 11 months
  • Diagnosis of bleeding disorder

You may not qualify if:

  • Acute bleed or injury in the last two weeks that prevents activity
  • Diagnosed developmental delay

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Oregon Health and Science University

Portland, Oregon, 97239, United States

Location

Patient's home

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Hemophilia A

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Bethany Sloane DPT,PCS, Assistant Professor

Study Record Dates

First Submitted

February 10, 2014

First Posted

October 31, 2014

Study Start

January 1, 2014

Primary Completion

January 1, 2022

Study Completion

January 1, 2022

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

There is a repository that is part of the consent process. Subjects can opt out if desired.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The manuscript is in progress. Once published, data will be available via the IRB approved repository if all conditions of the recipient IRB and the OHSU IRB are met.
Access Criteria
Approval of recipient and OHSU IRBs, respository guardian's approval.

Locations